SCHEMBL1631902

SCHEMBL1631902

NS(=O)(=O)c1ccc(Nc2ncc3cc(Br)cc(OC4CCNCC4)c3n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 6/20 0.48
CHUK O15111 4/20 0.48
AKT1 P31749 1/20 0.48
ROCK1 Q13464 1/20 0.48
JAK2 O60674 1/20 0.48
JAK1 P23458 1/20 0.48
TYK2 P29597 1/20 0.48
JAK3 P52333 1/20 0.48
IGF1R P08069 1/20 0.47
CDK1 P06493 3/20 0.44
CDK2 P24941 3/20 0.44
CDK9 P50750 3/20 0.44
CCNT1 O60563 2/20 0.44
CDK7 P50613 2/20 0.44
CCNH P51946 2/20 0.44
CCNB1 P14635 1/20 0.44
SYK P43405 2/20 0.42
TNIK Q9UKE5 1/20 0.42
CA2 P00918 5/20 0.41
STK4 Q13043 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12764372 0.89 IKBKB (0.48) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL17529314 0.86 JAK2 (0.55) IKBKBCHUKROCK1JAK2JAK1
SCHEMBL1633545 0.85 JAK2 (0.65) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1633346 0.85 CDK2 (0.43) IKBKBJAK2JAK1TYK2JAK3
SCHEMBL1632091 0.84 IKBKB (0.47) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL1633008 0.83 CDK1 (0.46) IKBKBCHUKAKT1ROCK1JAK2
SCHEMBL4059017 0.82 IGF1R (0.51) IKBKBCHUKAKT1ROCK1IGF1R
SCHEMBL1631095 0.81 STK4 (0.45) IKBKBIGF1RCDK1CDK2CDK9
SCHEMBL1570832 0.81 CA2 (0.52) IKBKBCDK1CDK2CDK9CCNT1
SCHEMBL1634422 0.80 JAK2 (0.58) IKBKBCHUKAKT1ROCK1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed